Last edition
News about "India Cracks Down on Misuse of GLP-1"
India Cracks Down on Misuse of GLP-1 Weight Loss Drugs Amid Semaglutide Surge
Central Drugs Standard Control Organisation has initiated a nationwide crackdown to curb potential malpractices in the pharmaceutical supply chain and prevent the unauthorized sale and misuse of GLP-1 receptor agonist-based weight loss drugs, following the rapid entry of multiple generic versions of semaglutide in India.
India Cracks Down On Misuse Of GLP-1 | 24/03/2026 | By Darshana | 106
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy